This reinforces the hypothesis that leptin and GDF-15 act through independent pathways in humans, which is consistent with a study in patients with lipodystrophy and hypoleptinemia, wherein leptin treatment failed to normalize GDF-15 levels31. The gene discussed is GDF15; the disease is lipodystrophy.